0000950170-23-065868.txt : 20231122 0000950170-23-065868.hdr.sgml : 20231122 20231122160511 ACCESSION NUMBER: 0000950170-23-065868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bellon Christine CENTRAL INDEX KEY: 0001963878 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39208 FILM NUMBER: 231433394 MAIL ADDRESS: STREET 1: BEAM THERAPEUTICS, INC. STREET 2: 238 MAIN STREET, 9TH FL. CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Beam Therapeutics Inc. CENTRAL INDEX KEY: 0001745999 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-327-8775 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 ownership.xml 4 X0508 4 2023-11-20 0001745999 Beam Therapeutics Inc. BEAM 0001963878 Bellon Christine C/O BEAM THERAPEUTICS INC., 238 MAIN STREET CAMBRIDGE MA 02142 false true false false Chief Legal Officer true Common Stock 2023-11-20 4 M false 4182 7.22 A 86584 D Common Stock 2023-11-20 4 M false 5818 7.22 A 92402 D Common Stock 2023-11-20 4 S false 5000 30.00 D 87402 D Common Stock 2023-11-20 4 S false 5000 31.00 D 82402 D Stock Option (Right to Buy) 7.22 2023-11-20 4 M false 4182 0 D 2029-05-16 Common Stock 4182 9492 D Stock Option (Right to Buy) 7.22 2023-11-20 4 M false 5818 0 D 2029-05-17 Common Stock 5818 10918 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. The option vests as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested. The option vests as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option is fully vested. By: /s/ Christine Bellon 2023-11-22